CDC Updates COVID-19 Vaccination Guidance

CDC has updated its guidance for COVID-19 vaccination. The summary of recent changes includes new guidance on COVID-19 vaccination and pemivibart (Pemgarda™), a monoclonal antibody authorized for COVID-19 pre-exposure prophylaxis in people who are moderately or severely immunocompromised and meet the FDA-authorized conditions for use.

To view all updates, visit CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States.